Tidal Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Tidal Investments's JAZZ Position: Q2 2026 in Review
Tidal Investments increased its Jazz Pharmaceuticals (JAZZ) stake by 8.3% in Q2 2026, buying an estimated $354K and bringing the position to 21,028 shares worth $5.07M. The position accounts for 0.01% of the portfolio, ranked #930.
Tidal Investments first reported a position in JAZZ in Q3 2022 and has held it in 16 quarters since. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- Tidal Investments held 21,028 shares of Jazz Pharmaceuticals worth $5.07M as of Q2 2026.
- Tidal Investments bought 1,615 Jazz Pharmaceuticals shares in Q2 2026, an estimated $354K.
- Jazz Pharmaceuticals made up 0.01% of Tidal Investments's portfolio in Q2 2026, its #930 holding.
- Tidal Investments first reported a position in Jazz Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
- 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.